Clin2
NCT07624422Possibly a fitNot yet recruiting

Helicobacter pylori infection treatment study

Helicobacter Pylori InfectionPeptic Ulcer DiseaseGastritis

Treatments studied

Part of Digestive system clinical trials.

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 80 years old
  • You have a confirmed H. pylori infection
  • You have not had prior treatment for H. pylori, or if you have, it did not work
  • You are willing to take the study medicine for 14 days and attend follow-up visits
  • If female and able to have children, you agree to use birth control and have a negative pregnancy test

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT06929962Recruiting· Phase 4
VA dual sequential therapy for H. pylori gastritis

This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.

Nanjing, Jiangsu
NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang
NCT07439445Recruiting
Simplified treatment for H. pylori guided by a stool test

This trial tests a simpler two-drug treatment for H. pylori infection, chosen based on a stool test that checks if the bacteria are resistant to clarithromycin. It may help people who have not been treated before avoid unnecessary antibiotics.

Beijing, Beijing Municipality
NCT06777732Not yet recruiting· Early Phase 1
Testing a new medicine for clearing H. pylori stomach infection

This study tests a new medicine called Keverprazan, which may help get rid of the H. pylori bacteria that causes stomach ulcers and other problems. If you have H. pylori and haven't been treated before, this trial could help you clear the infection with a new approach.

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.